Vivos Inc (RDGL)

$0.08 0.00 (-4.67%)
Market Cap 38.24M
Revenue (ttm) 70,000.00
Net Income (ttm) -3.07M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,385.71%
Debt to Equity Ratio 0.00
Volume 692,700
Avg Vol 733,712
Day's Range N/A - N/A
Shares Out 482.84M
Stochastic %K 42%
Beta -0.64
Analysts Strong Buy
Price Target N/A

Company Profile

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. The company develops an yttrium-90 based precision radionuclide therapy device; RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. It is also developing a universal laboratory cooling device; hydro...

Industry: Medical Devices
Sector: Healthcare
Phone: 509 222 2222
Address:
1030 N Center Parkway, Suite N288, Kennewick, United States
anderson800
anderson800 Apr. 14 at 10:32 AM
$RDGL Grok thinks that Tuesday (Wednesday 2nd favorite) is the favorite day for Vivos to announce submission, but also thinks next week is more likely than this week. We will see.
0 · Reply
SparksEE
SparksEE Apr. 11 at 10:26 PM
$RDGL LET'S GO!
1 · Reply
jhmlty
jhmlty Apr. 10 at 4:50 PM
$RDGL Nice day...people losing faith. It is irresponsible to mention big news for the end of Q1 and the beginning of Q2 without following through.
2 · Reply
anderson800
anderson800 Apr. 10 at 11:33 AM
$RDGL At the time of submission, I would like to hear more from the company on how the company will proceed depending on whether the FDA designates the device as Class III or hopefully Class II. It will be a win regardless of what classification it gets, but Class II would be a BIG BIG win.
2 · Reply
Lochlank
Lochlank Apr. 9 at 7:58 PM
$RDGL almost 5M volume today, all we need is an amazing news day and the volume will send us
2 · Reply
Doccjc62
Doccjc62 Apr. 9 at 5:21 PM
$RDGL I hear daybyday5 is still posting FUD. One good thing out of a near term decision is that she might sell and move on soon,,(if she actually owns shares). Although she did say that she was waiting to sell until the share price was over $1.50.. I guess it makes sense to bash a stock while you're waiting to sell over $1.50
1 · Reply
Doccjc62
Doccjc62 Apr. 9 at 3:38 PM
$RDGL Over 3.1 mil shares traded. I'm seeing over 3 mil were buys and 81,000 were sells... Welcome to the OTC.. Someone is accumulating. That's a lot of shares bought today.
0 · Reply
Daybyday5
Daybyday5 Apr. 9 at 3:23 PM
$RDGL Yay! Volume! hopefully that means insider trading and they're submitting tomorrow
1 · Reply
Lochlank
Lochlank Apr. 8 at 8:05 PM
$RDGL they did say early April for news release, we only have maybe till mid next week to hear something. They absolutely need to put something out this week. I am as bullish as they come on the stock but the company is showing they dont care about investors right now
1 · Reply
Fireballmillionaire
Fireballmillionaire Apr. 8 at 2:41 PM
$RDGL strong hands as we continue to wait... nothing out of the ordinary here.. slow process.. prices and lack of volume are due to this..
0 · Reply
Latest News on RDGL
No data available.
anderson800
anderson800 Apr. 14 at 10:32 AM
$RDGL Grok thinks that Tuesday (Wednesday 2nd favorite) is the favorite day for Vivos to announce submission, but also thinks next week is more likely than this week. We will see.
0 · Reply
SparksEE
SparksEE Apr. 11 at 10:26 PM
$RDGL LET'S GO!
1 · Reply
jhmlty
jhmlty Apr. 10 at 4:50 PM
$RDGL Nice day...people losing faith. It is irresponsible to mention big news for the end of Q1 and the beginning of Q2 without following through.
2 · Reply
anderson800
anderson800 Apr. 10 at 11:33 AM
$RDGL At the time of submission, I would like to hear more from the company on how the company will proceed depending on whether the FDA designates the device as Class III or hopefully Class II. It will be a win regardless of what classification it gets, but Class II would be a BIG BIG win.
2 · Reply
Lochlank
Lochlank Apr. 9 at 7:58 PM
$RDGL almost 5M volume today, all we need is an amazing news day and the volume will send us
2 · Reply
Doccjc62
Doccjc62 Apr. 9 at 5:21 PM
$RDGL I hear daybyday5 is still posting FUD. One good thing out of a near term decision is that she might sell and move on soon,,(if she actually owns shares). Although she did say that she was waiting to sell until the share price was over $1.50.. I guess it makes sense to bash a stock while you're waiting to sell over $1.50
1 · Reply
Doccjc62
Doccjc62 Apr. 9 at 3:38 PM
$RDGL Over 3.1 mil shares traded. I'm seeing over 3 mil were buys and 81,000 were sells... Welcome to the OTC.. Someone is accumulating. That's a lot of shares bought today.
0 · Reply
Daybyday5
Daybyday5 Apr. 9 at 3:23 PM
$RDGL Yay! Volume! hopefully that means insider trading and they're submitting tomorrow
1 · Reply
Lochlank
Lochlank Apr. 8 at 8:05 PM
$RDGL they did say early April for news release, we only have maybe till mid next week to hear something. They absolutely need to put something out this week. I am as bullish as they come on the stock but the company is showing they dont care about investors right now
1 · Reply
Fireballmillionaire
Fireballmillionaire Apr. 8 at 2:41 PM
$RDGL strong hands as we continue to wait... nothing out of the ordinary here.. slow process.. prices and lack of volume are due to this..
0 · Reply
jhmlty
jhmlty Apr. 7 at 9:01 PM
$RDGL Starting Q2 with nothing. What is this, jumping into to double dutch? Give us some news, good or bad.
1 · Reply
Daybyday5
Daybyday5 Apr. 7 at 5:05 PM
$RDGL IDE submission 04/31/26!!!!
2 · Reply
Rogggggg
Rogggggg Apr. 3 at 4:30 PM
$RDGL haha
0 · Reply
dandanthefireman
dandanthefireman Apr. 2 at 8:22 PM
$RDGL No not great, might have to bail
4 · Reply
Daybyday5
Daybyday5 Apr. 1 at 9:12 PM
$RDGL not great
3 · Reply
Doccjc62
Doccjc62 Apr. 1 at 7:01 PM
$RDGL Short trading week…. RDGL likely holding back news, especially the FDA IDE submission for RadioGel. Next full week looks prime for updates.This week is a good time to add imo
0 · Reply
Doccjc62
Doccjc62 Mar. 31 at 4:32 PM
$RDGL We are targeting breakeven in the Animal Therapy Division (IsoPet) by mid-2026. Lots happening in 2026. Upon successful qualification, the 2026 Regulation A+ Offering would provide expanded capacity for equity fundraising to further advance RadioGel® human therapy development (including IDE submission and potential approval for clinical trials), scale IsoPet® commercialization (targeting breakeven in the Animal Therapy Division in 2026), support VSIL initiatives for local manufacturing and clinical trials in India, mitigate single-site production risks through multi-facility operations (targeted for 2026 readiness), and pursue broader global access to the Precision Radionuclide Therapy™ platform in both human and veterinary oncology. The Company continues to monitor cash needs closely and explore additional financing avenues as it progresses toward regulatory milestones and operational profitability.
0 · Reply
anderson800
anderson800 Mar. 31 at 12:22 PM
$RDGL Revenue from treatments did not quite crack 6 digits but went up just shy of 200% increase from $29,995 in 2024 to $88,875 in 2025. If they can duplicate that percentage increase in 2026, they will be well on their way.
4 · Reply
anderson800
anderson800 Mar. 31 at 12:18 PM
$RDGL this may be mostly repeat from last:
0 · Reply
anderson800
anderson800 Mar. 31 at 12:10 PM
$RDGL 10K just dropped. Have not had a lot of time to disect yet, but had $1,558,525 cash on hand at end of 2025 and raised another $1,553,000 in March 2026. I would expect that our next cash raise will be at a much higher stock price as long as IDE goes according to plan.
1 · Reply
Doccjc62
Doccjc62 Mar. 29 at 7:00 PM
$RDGL Big week coming up for RDGL. 10K should drop any day now, IDE resubmission targeted for end of March or early April, and DCGI decision in India for expanded human trials could land soon too. Lots of potential catalysts in play ,,,, let's see what hits.
0 · Reply
Doccjc62
Doccjc62 Mar. 28 at 3:30 AM
$RDGL Significant progress made toward resubmitting the IDE application, targeted for end of Q1 / early April. RadioGel already holds FDA Breakthrough Device Designation. The updated package includes new human data from India, strengthened preclinicals, safety from 100+ veterinary treatments with zero serious adverse events, and guidance from a highly qualified FDA-experienced regulatory consultant. This is not the same submission as before. The team is addressing prior feedback with a materially stronger file. Real progress is happening. Very excited for the next few weeks,days?
1 · Reply